BOSTON, Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The rankings were revealed today on the CNS Summit 2026 main stage at Encore Boston Harbor. Now in its 11th year, the Index ranks the top 30 pharmaceutical companies on digital innovation, using publicly reported initiatives and investments from July 2025 through July 2026. The 2026 top 10 are Sanofi, Eli Lilly, AstraZeneca, Chugai, Roche, Bristol Myers Squibb, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim and Merck KGaA.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.